A Phase 1 Safety Study in Adults With Schizophrenia
NCT02804568
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
ALKS 3831
Sponsor
Alkermes, Inc.